BeStock  
Stocks › Medical Devices › SIBN

Si-Bone SIBN

US equityMarket cap rank #3350Medical Devices
$19.10 −$0.45 (-2.30%)
Market closed · Oct 8, 4:10 am ET · Last extended-hours $19.10 0.00%
Open$19.27
Prev close$19.55
Day range$18.98 – $19.69
Volume547.6K
Market cap$856.03M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong uptrend

7 bullish · 0 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average+2.3%BullishTrading above the 20-day average of $18.66
Price vs 50-day average+1.7%BullishTrading above the 50-day average of $18.78
Price vs 200-day average+16.9%BullishTrading above the 200-day average of $16.34
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)53.7BullishMomentum leans positive
MACD (12,26,9)0.14BullishMACD line is above its signal line
Bollinger band position74%BullishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$18.66+2.3%
50-day SMA$18.78+1.7%
200-day SMA$16.34+16.9%

Recent price levels

LevelPrice
20-day high$20.00
20-day low$17.82
60-day high$20.30
60-day low$16.26
Upper Bollinger band$19.58
Lower Bollinger band$17.74

The 50-day average is currently 14.9% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility35.1%
Average true range3.78% of price
Max drawdown (1y)-45.7%
Volume (10d vs 90d)1.06x

Discussion

No comments yet — be the first to weigh in on SIBN.

Leave a comment

Scroll to Top